Showing 1–6 of 6 results for author: Hardan, S

crossMoDA Challenge: Evolution of Cross-Modality Domain Adaptation Techniques for Vestibular Schwannoma and Cochlea Segmentation from 2021 to 2023

Authors: Navodini Wijethilake, Reuben Dorent, Marina Ivory, Aaron Kujawa, Stefan Cornelissen, Patrick Langenhuizen, Mohamed Okasha, Anna Oviedova, Hexin Dong, Bogyeong Kang, Guillaume Sallé, Luyi Han, Ziyuan Zhao, Han Liu, Tao Yang, Shahad Hardan, Hussain Alasmawi, Santosh Sanjeev, Yuzhou Zhuang, Satoshi Kondo, Maria Baldeon Calisto, Shaikh Muhammad Uzair Noman, Cancan Chen, Ipek Oguz, Rongguo Zhang , et al. (14 additional authors not shown)

Abstract: The cross-Modality Domain Adaptation (crossMoDA) challenge series, initiated in 2021 in conjunction with the International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI), focuses on unsupervised cross-modality segmentation, learning from contrast-enhanced T1 (ceT1) and transferring to T2 MRI. The task is an extreme example of domain shift chosen to serve as a mea… ▽ More The cross-Modality Domain Adaptation (crossMoDA) challenge series, initiated in 2021 in conjunction with the International Conference on Medical Image Computing and Computer Assisted Intervention (MICCAI), focuses on unsupervised cross-modality segmentation, learning from contrast-enhanced T1 (ceT1) and transferring to T2 MRI. The task is an extreme example of domain shift chosen to serve as a meaningful and illustrative benchmark. From a clinical application perspective, it aims to automate Vestibular Schwannoma (VS) and cochlea segmentation on T2 scans for more cost-effective VS management. Over time, the challenge objectives have evolved to enhance its clinical relevance. The challenge evolved from using single-institutional data and basic segmentation in 2021 to incorporating multi-institutional data and Koos grading in 2022, and by 2023, it included heterogeneous routine data and sub-segmentation of intra- and extra-meatal tumour components. In this work, we report the findings of the 2022 and 2023 editions and perform a retrospective analysis of the challenge progression over the years. The observations from the successive challenge contributions indicate that the number of outliers decreases with an expanding dataset. This is notable since the diversity of scanning protocols of the datasets concurrently increased. The winning approach of the 2023 edition reduced the number of outliers on the 2021 and 2022 testing data, demonstrating how increased data heterogeneity can enhance segmentation performance even on homogeneous data. However, the cochlea Dice score declined in 2023, likely due to the added complexity from tumour sub-annotations affecting overall segmentation performance. While progress is still needed for clinically acceptable VS segmentation, the plateauing performance suggests that a more challenging cross-modal task may better serve future benchmarking. △ Less

Submitted 13 June, 2025; originally announced June 2025.

Efficient Parameter Adaptation for Multi-Modal Medical Image Segmentation and Prognosis

Authors: Numan Saeed, Shahad Hardan, Muhammad Ridzuan, Nada Saadi, Karthik Nandakumar, Mohammad Yaqub

Abstract: Cancer detection and prognosis relies heavily on medical imaging, particularly CT and PET scans. Deep Neural Networks (DNNs) have shown promise in tumor segmentation by fusing information from these modalities. However, a critical bottleneck exists: the dependency on CT-PET data concurrently for training and inference, posing a challenge due to the limited availability of PET scans. Hence, there i… ▽ More Cancer detection and prognosis relies heavily on medical imaging, particularly CT and PET scans. Deep Neural Networks (DNNs) have shown promise in tumor segmentation by fusing information from these modalities. However, a critical bottleneck exists: the dependency on CT-PET data concurrently for training and inference, posing a challenge due to the limited availability of PET scans. Hence, there is a clear need for a flexible and efficient framework that can be trained with the widely available CT scans and can be still adapted for PET scans when they become available. In this work, we propose a parameter-efficient multi-modal adaptation (PEMMA) framework for lightweight upgrading of a transformer-based segmentation model trained only on CT scans such that it can be efficiently adapted for use with PET scans when they become available. This framework is further extended to perform prognosis task maintaining the same efficient cross-modal fine-tuning approach. The proposed approach is tested with two well-known segementation backbones, namely UNETR and Swin UNETR. Our approach offers two main advantages. Firstly, we leverage the inherent modularity of the transformer architecture and perform low-rank adaptation (LoRA) as well as decomposed low-rank adaptation (DoRA) of the attention weights to achieve parameter-efficient adaptation. Secondly, by minimizing cross-modal entanglement, PEMMA allows updates using only one modality without causing catastrophic forgetting in the other. Our method achieves comparable performance to early fusion, but with only 8% of the trainable parameters, and demonstrates a significant +28% Dice score improvement on PET scans when trained with a single modality. Furthermore, in prognosis, our method improves the concordance index by +10% when adapting a CT-pretrained model to include PET scans, and by +23% when adapting for both PET and EHR data. △ Less

Submitted 18 April, 2025; originally announced April 2025.

Understanding Breast Cancer Survival: Using Causality and Language Models on Multi-omics Data

Authors: Mugariya Farooq, Shahad Hardan, Aigerim Zhumbhayeva, Yujia Zheng, Preslav Nakov, Kun Zhang

Abstract: The need for more usable and explainable machine learning models in healthcare increases the importance of developing and utilizing causal discovery algorithms, which aim to discover causal relations by analyzing observational data. Explainable approaches aid clinicians and biologists in predicting the prognosis of diseases and suggesting proper treatments. However, very little research has been c… ▽ More The need for more usable and explainable machine learning models in healthcare increases the importance of developing and utilizing causal discovery algorithms, which aim to discover causal relations by analyzing observational data. Explainable approaches aid clinicians and biologists in predicting the prognosis of diseases and suggesting proper treatments. However, very little research has been conducted at the crossroads between causal discovery, genomics, and breast cancer, and we aim to bridge this gap. Moreover, evaluation of causal discovery methods on real data is in general notoriously difficult because ground-truth causal relations are usually unknown, and accordingly, in this paper, we also propose to address the evaluation problem with large language models. In particular, we exploit suitable causal discovery algorithms to investigate how various perturbations in the genome can affect the survival of patients diagnosed with breast cancer. We used three main causal discovery algorithms: PC, Greedy Equivalence Search (GES), and a Generalized Precision Matrix-based one. We experiment with a subset of The Cancer Genome Atlas, which contains information about mutations, copy number variations, protein levels, and gene expressions for 705 breast cancer patients. Our findings reveal important factors related to the vital status of patients using causal discovery algorithms. However, the reliability of these results remains a concern in the medical domain. Accordingly, as another contribution of the work, the results are validated through language models trained on biomedical literature, such as BlueBERT and other large language models trained on medical corpora. Our results profess proper utilization of causal discovery algorithms and language models for revealing reliable causal relations for clinical applications. △ Less

Submitted 28 May, 2023; originally announced May 2023.

Weakly Unsupervised Domain Adaptation for Vestibular Schwannoma Segmentation

Authors: Shahad Hardan, Hussain Alasmawi, Xiangjian Hou, Mohammad Yaqub

Abstract: Vestibular schwannoma (VS) is a non-cancerous tumor located next to the ear that can cause hearing loss. Most brain MRI images acquired from patients are contrast-enhanced T1 (ceT1), with a growing interest in high-resolution T2 images (hrT2) to replace ceT1, which involves the use of a contrast agent. As hrT2 images are currently scarce, it is less likely to train robust machine learning models t… ▽ More Vestibular schwannoma (VS) is a non-cancerous tumor located next to the ear that can cause hearing loss. Most brain MRI images acquired from patients are contrast-enhanced T1 (ceT1), with a growing interest in high-resolution T2 images (hrT2) to replace ceT1, which involves the use of a contrast agent. As hrT2 images are currently scarce, it is less likely to train robust machine learning models to segment VS or other brain structures. In this work, we propose a weakly supervised machine learning approach that learns from only ceT1 scans and adapts to segment two structures from hrT2 scans: the VS and the cochlea from the crossMoDA dataset. Our model 1) generates fake hrT2 scans from ceT1 images and segmentation masks, 2) is trained using the fake hrT2 scans, 3) predicts the augmented real hrT2 scans, and 4) is retrained again using both the fake and real hrT2. The final result of this model has been computed on an unseen testing dataset provided by the 2022 crossMoDA challenge organizers. The mean dice score and average symmetric surface distance (ASSD) are 0.78 and 0.46, respectively. The predicted segmentation masks achieved a dice score of 0.83 and an ASSD of 0.56 on the VS, and a dice score of 0.74 and an ASSD of 0.35 on the cochleas. △ Less

Submitted 13 March, 2023; originally announced March 2023.

Energy Pricing in P2P Energy Systems Using Reinforcement Learning

Authors: Nicolas Avila, Shahad Hardan, Elnura Zhalieva, Moayad Aloqaily, Mohsen Guizani

Abstract: The increase in renewable energy on the consumer side gives place to new dynamics in the energy grids. Participants in a microgrid can produce energy and trade it with their peers (peer-to-peer) with the permission of the energy provider. In such a scenario, the stochastic nature of distributed renewable energy generators and energy consumption increases the complexity of defining fair prices for… ▽ More The increase in renewable energy on the consumer side gives place to new dynamics in the energy grids. Participants in a microgrid can produce energy and trade it with their peers (peer-to-peer) with the permission of the energy provider. In such a scenario, the stochastic nature of distributed renewable energy generators and energy consumption increases the complexity of defining fair prices for buying and selling energy. In this study, we introduce a reinforcement learning framework to help solve this issue by training an agent to set the prices that maximize the profit of all components in the microgrid, aiming to facilitate the implementation of P2P grids in real-life scenarios. The microgrid considers consumers, prosumers, the service provider, and a community battery. Experimental results on the \textit{Pymgrid} dataset show a successful approach to price optimization for all components in the microgrid. The proposed framework ensures flexibility to account for the interest of these components, as well as the ratio of consumers and prosumers in the microgrid. The results also examine the effect of changing the capacity of the community battery on the profit of the system. The implementation code is available \href{https://github.com/Artifitialleap-MBZUAI/rl-p2p-price-prediction}{here}. △ Less

Submitted 24 October, 2022; originally announced October 2022.

Is it Possible to Predict MGMT Promoter Methylation from Brain Tumor MRI Scans using Deep Learning Models?

Authors: Numan Saeed, Shahad Hardan, Kudaibergen Abutalip, Mohammad Yaqub

Abstract: Glioblastoma is a common brain malignancy that tends to occur in older adults and is almost always lethal. The effectiveness of chemotherapy, being the standard treatment for most cancer types, can be improved if a particular genetic sequence in the tumor known as MGMT promoter is methylated. However, to identify the state of the MGMT promoter, the conventional approach is to perform a biopsy for… ▽ More Glioblastoma is a common brain malignancy that tends to occur in older adults and is almost always lethal. The effectiveness of chemotherapy, being the standard treatment for most cancer types, can be improved if a particular genetic sequence in the tumor known as MGMT promoter is methylated. However, to identify the state of the MGMT promoter, the conventional approach is to perform a biopsy for genetic analysis, which is time and effort consuming. A couple of recent publications proposed a connection between the MGMT promoter state and the MRI scans of the tumor and hence suggested the use of deep learning models for this purpose. Therefore, in this work, we use one of the most extensive datasets, BraTS 2021, to study the potency of employing deep learning solutions, including 2D and 3D CNN models and vision transformers. After conducting a thorough analysis of the models' performance, we concluded that there seems to be no connection between the MRI scans and the state of the MGMT promoter. △ Less

Submitted 26 February, 2022; v1 submitted 16 January, 2022; originally announced January 2022.